Transgenic approaches to model Alzheimer's disease

Reviews in the Neurosciences

Volumn 11, Issue 1, 2000, Pages 47-51

  Sommer, Bernd ^a   Sturchler Pierrat, Christine ^a   Abramowski, Dorothee ^a   Wiederhold, Karl Heinz ^a   Calhoun, Michael ^b   Jucker, Mathias ^b   Kelly, Peter ^a   Staufenbiel, Matthias ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Alzheimer's disease; APP 23 mice; Beta amyloid precursor protein; Model; Transgenic mice

Indexed keywords

AMYLOID PRECURSOR PROTEIN; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; BRAIN NERVE CELL; CHOLINERGIC NERVE; CONFERENCE PAPER; DISEASE SEVERITY; GENE MUTATION; HIPPOCAMPUS; LATENT PERIOD; MAZE TEST; MOLECULAR MODEL; MOUSE; NERVE CELL; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SENILE PLAQUE; STEREOLOGY; TRANSGENIC MOUSE;

EID: 0033988395     PISSN: 03341763     EISSN: None     Source Type: Journal    
DOI: 10.1515/REVNEURO.2000.11.1.47     Document Type: Conference Paper

References (15)

1. Alzheimer A. Über eine eigenartige Erkrankung der Hirnrinde. Allg Z Psychiatr 1907; 64: 146-148.
2. Andrä K, Abramowski D, Duke M, Wiederhold K-H, Probst A, Bürki K, Goedert M, Sommer B, Staufenbiel M. Comparison of neuron-specific promoters for the generation of app transgenic mice. Neurobiol Aging 1996; 17: 183-190.
3. Borchelt DR, Ratovitski T, van-Lare J, Lee MK, Gonzales V, Jenkins NA, Copeland NG, Price DL, Sisodia SS. Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron 1997; 19: 939-945.
4. Calhoun ME, Wiederhold K-H, Abramowski D, Phinney AL, Probst A, Sturchler-Pierrat C, Staufenbiel M, Sommer B, Jucker M. Amyloid plaques and neuronal death in APP transgenic mice. Nature 1998; 395: 755-756.
5. Citron M, Oltersdorf T, Haass C, McConlogue L, Hung AY, Seubert P, Vigo-Pelfrey C, Lieberburg I, Selkoe DJ. Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. Nature 1992; 360: 672-674.
6. Gallyas F. Silver staining of Alzheimer's neurofibrillary changes by means of physical development. Acta Morphol Acad Sci Hung 1971; 19: 1-8.
7. Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L, Mant R, Newton P, Rooke K, Roques P, Talbot C, Pericak-Vance M, Roses A, Williamson R, Rossor M, Qwen M, Hardy J. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991; 349: 704-706.
8. Goedert M. Tau protein and the neurofibrillary pathology of Alzheimer's disease. Trends Neurosci 1993; 16: 460-465.
9. Hardy J. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci 1997; 20: 154-159.
10. Holcomb L, Gordon MN, McGowan E, Yu X, Benkovic S, Jantzen P, Wright K, Saad I, Mueller R, Morgan D, Sanders S, Zehr C, O'Campo K, Hardy J, Prada CM, Eckman C, Younkin S, Hsiao K, Duff K. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nature Med 1998; 4: 97-100.
11. Iqbal K. Prevalence and neurobiology of Alzheimer's disease: Some highlights. In: Iqbal K, McLachlan DRC, Winblad B, Wisniewsky HM, eds. Alzheimers Disease: Basic Mechanisms. Diagnosis and Therapeutic Strategies. Chichester: Wiley, 1991; 1-5.
12. Mullan M, Crawford F, Axelman K, Houlden H, Lilius L, Winblad B, Lannfelt L. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid. Nat Genet 1992; 1: 345-347.
13. Sturchler-Pierrat C, Abramowski D, Duke M, Wiederhold K-H, Mistl C, Rothacher S, Ledermann B, Bürki K, Frey P, Paganetti PA, Waridel C, Jucker M, Calhoun M, Probst A, Staufenbiel M, Sommer B. Two APP transgenic mouse models with Alzheimer's disease-like pathology. Proc Natl Acad Sci USA 1997; 94: 13287-13209.
14. Suzuki N, Cheung TT, Cai XD, Odaka A, Otvos L Jr, Eckman C, Golde TE, Younkin SG. An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. Science 1994; 264: 1336-1340.
15. Yankner BA. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 1996; 16: 921-932.